CALABRESE, EMMA
 Distribuzione geografica
Continente #
NA - Nord America 31.669
AS - Asia 5.800
EU - Europa 3.861
SA - Sud America 685
Continente sconosciuto - Info sul continente non disponibili 590
AF - Africa 77
OC - Oceania 3
Totale 42.685
Nazione #
US - Stati Uniti d'America 31.401
SG - Singapore 3.683
IT - Italia 905
CN - Cina 809
BR - Brasile 560
RU - Federazione Russa 475
DE - Germania 455
HK - Hong Kong 369
UA - Ucraina 365
IE - Irlanda 353
VN - Vietnam 337
SE - Svezia 314
FR - Francia 266
FI - Finlandia 221
GB - Regno Unito 202
BD - Bangladesh 167
CA - Canada 114
JP - Giappone 109
KR - Corea 80
IN - India 68
NL - Olanda 58
PL - Polonia 50
BE - Belgio 45
EC - Ecuador 37
AR - Argentina 33
MX - Messico 30
TR - Turchia 30
CZ - Repubblica Ceca 29
ES - Italia 25
ZA - Sudafrica 25
AT - Austria 24
IQ - Iraq 23
HN - Honduras 19
JM - Giamaica 19
SV - El Salvador 19
CR - Costa Rica 18
VE - Venezuela 18
ID - Indonesia 17
DK - Danimarca 14
GT - Guatemala 13
MA - Marocco 12
PH - Filippine 11
EG - Egitto 10
PK - Pakistan 10
UZ - Uzbekistan 10
CL - Cile 9
CO - Colombia 9
EE - Estonia 9
PR - Porto Rico 9
SA - Arabia Saudita 9
CH - Svizzera 8
GR - Grecia 8
TN - Tunisia 8
CW - ???statistics.table.value.countryCode.CW??? 7
EU - Europa 7
IL - Israele 7
NI - Nicaragua 7
PE - Perù 7
PY - Paraguay 7
TH - Thailandia 7
KG - Kirghizistan 6
JO - Giordania 5
LB - Libano 5
RO - Romania 5
BG - Bulgaria 4
DZ - Algeria 4
GP - Guadalupe 4
HR - Croazia 4
LT - Lituania 4
PS - Palestinian Territory 4
RS - Serbia 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AM - Armenia 3
BH - Bahrain 3
BS - Bahamas 3
IR - Iran 3
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
PA - Panama 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
CI - Costa d'Avorio 2
CY - Cipro 2
DM - Dominica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
GY - Guiana 2
MD - Moldavia 2
NG - Nigeria 2
PT - Portogallo 2
QA - Qatar 2
Totale 42.092
Città #
Woodbridge 7.909
Houston 6.654
Wilmington 6.635
Singapore 1.050
Ashburn 930
Fairfield 925
Ann Arbor 833
San Jose 682
Chandler 463
Seattle 419
Hong Kong 365
Cambridge 328
Jacksonville 324
Dublin 317
Dallas 314
Beijing 273
Santa Clara 249
Council Bluffs 246
Rome 244
Medford 235
Dearborn 185
New York 178
The Dalles 167
Los Angeles 158
Helsinki 127
Lawrence 110
Ho Chi Minh City 102
Tokyo 94
Zhengzhou 81
Milan 78
Lauterbourg 75
Buffalo 74
Hanoi 68
Moscow 65
San Diego 64
Boardman 61
North Bergen 58
Munich 51
Atlanta 46
Brussels 45
Denver 45
Menlo Park 40
São Paulo 40
Mülheim 35
Chicago 34
Orem 32
Phoenix 31
Shanghai 31
Nuremberg 29
Toronto 28
Rio de Janeiro 27
London 26
Redondo Beach 25
Columbus 24
Kraków 24
Naples 24
Brooklyn 22
Chennai 22
Norwalk 22
Philadelphia 21
Redwood City 21
Warsaw 19
Belo Horizonte 18
Frankfurt am Main 18
Amsterdam 17
Boston 17
Florence 17
Lappeenranta 17
Montreal 17
North Charleston 17
Brno 16
Nanjing 16
Quito 16
Verona 16
Palo Alto 15
Guayaquil 14
Bologna 13
Kingston 13
San Salvador 13
University Park 13
Vienna 13
Washington 13
Brasília 12
Charlotte 12
Haiphong 12
Hefei 12
Manchester 12
San José 12
Baghdad 11
Indianapolis 11
Johannesburg 11
Miami 11
San Francisco 11
Seoul 11
Colorado Springs 10
Da Nang 10
Jakarta 10
Kilburn 10
Kunming 10
Mountain View 10
Totale 32.411
Nome #
Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up 702
Small intestine contrast ultrasonography vs computed tomography enteroclysis for assessing ileal Crohn's disease. 635
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 624
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: a prospective longitudinal study 619
Wireless capsule endoscopy in Crohn’s disease: clinical relevance of upper GI lesions and feasibility 2 years after ileo-colonic resection. 610
Steroid-free remission and closure of recto-vaginal fistula using adalimumab in a Crohn's disease patient naïve to anti-tumour necrosis factor alpha antibodies 587
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 579
In Crohn's Disease Colonic Mucins Are Expressed in the Established Ileal Lesions at Surgery While heal Mucins Are Mainly Expressed in the Early Ileal Recurrence: A Prospective Longitudinal Study 573
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 572
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis? 569
Ultrasound of the small bowel in Crohn's disease 554
ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian Population 548
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 544
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 535
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 529
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study 528
Cancer and immunomodulators in inflammatory bowel diseases 521
A family study of asymptomatic small bowel Crohn's disease 515
Local injection of infliximab in the postoperative recurrence of Crohn's disease 513
Infliximab and newly diagnosed neoplasia in Crohn's disease: A multicentre matched pair study 505
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study 499
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 499
Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study 498
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 497
Surgery for fistula-in-ano in a specialist colorectal unit: a critical appraisal 492
Ultrasound in Crohns Disease 490
Accuracy of Small Intestine Contrast Ultrasonography, Compared to Computed Tomography Enteroclysis, in Characterizing Lesions in Patients with Crohn's Disease. 488
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: relationship with colonic metaplasia 486
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study 485
Planck 2013 results. I. Overview of products and scientific results 484
Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: A novel recognizable microdeletion syndrome? 483
Planck 2013 results. XV. CMB power spectra and likelihood 478
Measuring disease activity in Crohn's disease 476
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study 476
1 470
Colonic Phenotype of the Ileum in Crohn's Disease: A Prospective Study Before and after Ileocolonic Resection. 469
A Sonographic Lesion Index for Crohn's Disease Helps Monitor Changes in Transmural Bowel Damage During Therapy 466
Ala197Thr is not associated with susceptibility to Crohn’s Disease or with phenotype in an Italian population. 466
Evolution of the Lesions Related to Crohn's Disease Recurrence As Assessed By Ultrasonography: A Prospective Longitudinal Study. 466
Antisense approach to inflammatory bowel disease: Prospects and challenges 465
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases 459
Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's disease. 456
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: A prospective longitudinal study 455
Frequency, pattern, and risk factors of postoperative recurrence of Crohn's disease after resection different from ileo-colonic 455
Is It Always Necessary to Treat CD Patients? 452
Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease 452
Bowel Ultrasonography for Timely Diagnosis of Intestinal Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation 452
Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease 450
Frequency, Pattern, and Risk Factors of Postoperative Recurrence of Crohn's Disease After Resection Different from Ileo-Colonic 443
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 443
Treatment with biologic therapies and the risk of cancer in patients with IBD. 441
Planck 2013 results. XXII. Constraints on inflation 440
Malattia di Crohn. In: Malattie del canale digerente. Gasbarrini G, Morelli A. 436
Capsule endoscopy and proximal small bowel lesions in patients with Crohn’s disease. 435
Wireless capsule endoscopy and proximal small bowel lesions in Crohn's disease. 433
Laparoscopic versus open ileo-colonic resection in Crohn's disease: short- and long-term results from a prospective longitudinal study 431
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 425
Comparison between techniques providing the luminal vs extraluminal surface in assessing Crohn’s disease recurrance: a prospective longitudinal study. 416
Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis 413
Diagnostic role of wireless capsule endoscopy in patients with symptoms highly compatible with Crohn's disease 411
null 409
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case–control IG-IBD study 399
Severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings 392
Cancer in Infliximab treated or untreated Crohn’s disease patients: a 2 years longer follow up from a multicenter matched-pair study.. 392
New biologic therapies in patients with Inflammatory Bowel Disease [Nuovi farmaci biologici nelle Malattie Infiammatorie Croniche Intestinali] 390
Severity of Crohn’s disease recurrence after ileo-colon resection: correlation between endoscopic score and sonographic findings. 385
Ileal lesions in patients with Ulcerative Colitis after ileo-rectal anastomosis: relationship with colonic metaplasia. 377
Assessment of Crohn’s disease recurrence after Ileo-colonic resection: correlation between endoscopic score and sonographic findings. 375
Endoscopic vs ultrasonographic findings related to Crohn's disease recurrence: a prospective longitudinal study at 3 years. 365
Newly diagnosed neoplasia in a cohort of Crohn’s disease patients treated with Infliximab: a 3 years longer follow up from a multicenter matched-pair study. 355
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 329
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 326
Malattia di Crohn. In: Malattie del canale digerente 312
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 291
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 287
The incidence and predictors of lupus-like reaction in patients with IBD treated with anti-TNF therapies 269
Extent of mucosal inflammation in ulcerative colitis influences the clinical remission induced by vedolizumab 250
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease 239
EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound 231
ECCO-ESGAR guideline for diagnostic assessment in ibd part 2: Ibd scores and general principles and technical aspects 219
Hepatic follicular lymphoma in an old patient with Crohn’s disease: a rare case and review of the literature 207
Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts. 203
Fecal and mucosal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease 194
Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter Study. 187
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 172
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 165
The impact of COVID-19 pandemic in the colorectal cancer prevention 158
High frequency of undiagnosed psychiatric disorders in inflammatory bowel diseases 149
Ultrasonography tight control and monitoring in Crohn's disease during different biological therapies: a multicenter study 147
Mucinous and Signet-Ring Cell Colonic Adenocarcinoma in Inflammatory Bowel Disease: A Case-Control Study 146
Post-operative recurrence of Crohn's disease: A prospective study at 5 years 137
Treatment with biologic therapies and the risk of cancer in patients with IBD 126
Niclosamide enema for active distal ulcerative colitis: a phase I, open-label study 124
Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases 120
Crohn's disease: A comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema 118
Preventable predictive factors of post-colonoscopy colorectal cancer in inflammatory bowel disease 114
Onset of ulcerative colitis during SARS-Cov-2 infection 113
EFSUMB Position Paper: Recommendations for Gastrointestinal Ultrasound (GIUS) in Acute Appendicitis and Diverticulitis 112
Concept design of the LiteBIRD satellite for CMB B-mode polarization 109
Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study 108
Totale 39.294
Categoria #
all - tutte 107.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 107.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.137 0 0 0 118 81 102 69 71 213 115 64 304
2022/20231.291 159 94 21 162 121 329 119 65 108 7 72 34
2023/2024523 56 16 34 16 63 127 38 48 5 22 7 91
2024/20254.924 90 721 373 211 79 252 250 118 426 236 1.232 936
2025/20265.592 398 256 793 461 391 196 699 699 607 508 305 279
2026/20272.750 480 529 1.005 736 0 0 0 0 0 0 0 0
Totale 42.685